Cogent Biosciences announced a debt financing facility of up to $400 million to support its growth plans, including bezuclastinib's launch. When will the results from the SUMMIT trial be reported?

Cogent Biosciences, Inc. - (GLOBE NEWSWIRE) Jun 11, 2025 Jun 11, 2025; Getting your Trinity Audio player ready... Facility provides additional funding for next steps of the Company’s growth, ...

James Bubeck, the Chief Revenue Officer of Cogent Communications Holdings, Inc. (NASDAQ: CCOI), recently sold 2,000 shares of the company’s common stock.The transaction, which took place on June ...

The U.S. Supreme Court on June 5 made it easier for workers to file so-called "reverse discrimination" lawsuits after siding with Ohio worker Marlean Ames who claimed she didn't get a job and was ...

Interview: Chrono Odyssey Seeks to Define Itself from Other Action MMORPGs The MMORPG's time-specific mechanics will bleed into the narrative, just as much as it does the gameplay.

The new definition of Liberation War drops the name of Bangabandhu Sheikh Mujibur Rahman. The previous one mentioned that the war was waged responding to Bangabandhu's call for independence.

Ask any successful person and they’ll tell you about an inspiring leader who paved the way. In my book, Underdog Nation, I call these people “Admirables.” ...

Washington Commanders wide receiver Deebo Samuel is arguably the biggest addition to the roster this offseason. The Commanders traded a fifth-round pick to the ...

Detroit’s legacy of freedom fighting stretches through every block, pulpit, and ballot box. The NAACP Detroit Branch’s 70th Annual Fight For Freedom Fund Dinner is rooted in that same tradition—an ...

Cogent is headquartered at 2450 N Street, NW, Washington, D.C. 20037. Cogent can be reached in the United States at (202) 295-4200 or via email at [email protected] .

Cogent Communications Holdings, Inc. (NASDAQ: CCOI) (the "Company" or "Cogent") today announced that two of its wholly owned subsidiaries, Cogent Communications Group, LLC (f/k/a Cogent ...